“About Natalie is groundbreaking. It doesn’t preach or pretend to offer a panacea. Instead, it offers a refreshing, authentic look at one family’s struggle with addiction, easily the most powerful book published on the subject in the 21st century.”— Dr. Maryel McKinley PhD, Addictions Expert, Former Co-Host, “All Talk Recovery Radio,” Los Angeles, Arbitron rated No. 1 in Southern California
Pittsburgh, PA, May 18, 2021 — Like the band that played on as the Titanic sank, Christine Naman unpacked the groceries and made a meatloaf — the simple act of normalcy distracting her from an unthinkable reality: addiction was pulling her daughter under.
“Even with the picture of the situation coming more clearly into focus, I clung to denial like a kayaker who has been thrown from his boat would cling to a branch lying across the water,”Christine says. “It is amazing how deep into denial a person can go and how strongly they can hang onto it before reality smacks them around enough so that they let go.”
Christinetraces her daughter's years-long battle with addiction in About Natalie, a gripping, cautionary tale of how, in spite of a loving family and a comfortable life, a child can end up on the wrong path, meet the wrong people and get lost in the unthinkable.
About Natalie takes readers deep inside Christine’s emotional and mental turmoil as she grows into her new, unfortunate role as the parent of an addict. She steps on syringes left on the floor and wrestles one from the family dog’s mouth. She lives the nightmare of finding an unresponsive child on the floor and uses Narcan to revive her. She chases away a drug dealer and stays up all night waiting for her missing child to come home. She rejoices during periods of recovery and hope and is devastated during relapses. When her daughter suffers, Christine suffers right along with her.
Interwoven with Christine’s reflections are Natalie’s compelling poems that share her personal pain and the unvarnished truth of her struggle.
At its core, About Natalie is a story of fighting for — and right alongside — the ones we love, no matter how difficult the circumstances. It is a story of keeping the faith, battling hard and never giving up.
Bestselling author Christine Pisera Naman is a wife to a beautiful man named Peter and a mother to three fantastic kids named Jason, Natalie and Trevor. In her free time, she enjoys crocheting, which she does poorly; painting, again poorly; and volunteering at her local hospital, which she hopes she does well. She is the author of the Faces of Hope series of books that are now housed in the 9/11 Memorial Museum in New York City. Her other works include Caterpillar Kisses, Christmas Lights, The Novena and The Believers.About Natalie is her heart poured onto paper.
She hopes that by sharing her family’s difficult story she can bring understanding and knowledge to those who do not know the problem firsthand as well as provide comfort to those who know the nightmare of addiction all too well.
Sandoz Canada congratulates the Quebec government on implementing a shift towards biosimilars
The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta and recently in New Brunswick to transition patients who use a reference biologic to a biosimilar. This will contribute to substantial annual savings that can be reinvested in healthcare and innovative new drugs.
The transition will take place under the supervision of the attending physicians and patients will continue receiving safe and effective treatment. Sandoz Canada has a portfolio of six biosimilars (Omnitrope, Rixymio, Erelzi, Hyrimoz, Ziextenzo and Inclunox).
Sandoz Canada is committed to supporting patients, their healthcare professionals and the Quebec government throughout the transition period with quality biosimilar medicines, medical teams, physician and pharmacist advocacy teams, as well as proven patient support programs.
BOUCHERVILLE, Quebec, May 18, 2021 (GLOBE NEWSWIRE) -- Sandoz Canada, a leader in generic pharmaceuticals and biosimilars, welcomes the Quebec Government’s shift towards biosimilars. According to the government’s announcement, this transition will generate annual savings of more than $100 for the public drug insurance plan and its insured parties. These savings will be reinvested in the healthcare system to improve access to innovative drug therapies, in particular.
Quebec is following the biosimilar transition policies implemented by British Columbia and Alberta in 2019 and, more recently, New Brunswick in 2021. With this announcement, the provinces that have adopted and implemented such a policy now make it possible for almost half of the Canadian population to benefit from it1. Under the Quebec initiative, the province will eventually cover only biosimilar drugs on formularies, with some exceptions, and will transition patients who use the reference biologic medicine to the listed biosimilar by April 12, 2022, under the supervision of their attending physicians.
“At Sandoz Canada, we are pleased to see that Quebec is adopting a switch policy already initiated by other provinces and is moving towards biosimilars. We are ready to support the government, physicians, pharmacists and all healthcare professionals with our six quality biosimilars, while helping to generate significant savings for the healthcare system,” said Michel Robidoux, President and General Manager, Sandoz Canada. “With COVID-19 placing our healthcare system under major budget constraints, biosimilar transition policies are an opportunity to contribute to the sustainability of health system financing and provide funding for new innovations,” he added.
“The government has stated its intention to engage in discussions with key healthcare partners, and Sandoz intends to actively cooperate in these discussions. We want to share our experience with the Ministry in order to provide patients with the highest quality of care. It will also be an opportunity to clarify certain details of the shift towards biosimilars, in particular with the new regulation (section 80.2) coming into effect as part of the Act respecting prescription drug insurance,” said Karine Matteau, Vice President, Bio-Generic Hospital/Physician channel and Head of Biosimilars at Sandoz Canada. “Sandoz is fully committed to supporting patients and their healthcare team during this transition period and beyond through our education initiatives and our patient support programs. We have set up a website for Canadians, BiosimilarsGeneration.ca, which contains a wealth of information and resources related to biosimilars,” she added.
About Biosimilars
A biosimilar is a biologic medicine that has demonstrated it is highly similar and has no clinically meaningful differences in efficacy and safety compared to the reference biologic already authorized for sale.2 Biosimilars may become commercially available following the expiry of patents and data protection periods of the reference biologic medicine.
The Patented Medicines Pricing Review Board has estimated that private and public drug plans across Canada could save from CA$294 million to CA$1.136 billion by 2021 for established biosimilars3 available in Canada for at least two years, and from CA$222 million to CA$447 million by 20234 for new biosimilars that recently entered the Canadian market.
For further information on biosimilars in Canada, visit BiosimilarsGeneration.ca, which aims to support and educate patients, healthcare professionals and Canadians by providing policy updates from public drug plans, as well as evidence-based information and resources from Canadian, international research and clinical communities, and patient organizations representing Canadians living with chronic diseases who take biologic medicines. In addition, the site also presents the positions of organizations that represent Canadian patients with chronic diseases who take biologic drugs.
Since 2009, Health Canada has authorized 36 biosimilars of reference biologics present on the Canadian market5 and Sandoz Canada has six of them marketed in the country (Omnitrope, Erelzi, Ziextenzo, Riximyo, Hyrimoz and Inclunox).
About transitioning
In the context of biosimilar use, Health Canada “considers switching between authorized products to refer to a change from routine use of one specific product to routine use of another specific product. Patients and healthcare providers can have confidence that biosimilars are effective and safe for each of their authorized indications. No differences are expected in efficacy and safety following a change in routine use between a biosimilar and its reference biologic drug in an authorized indication.”6
About Sandoz Canada
Sandoz International GmbH is a world leader in generics and biosimilars and a division of the Swiss multinational Novartis.
Sandoz Canada is a pioneer, a leader and trusted supplier of quality generics and biosimilars with over 65 million prescriptions per year, based on decades of global experience and capabilities in the development, manufacturing and commercialization of its products. Sandoz launched the first biosimilar in Europe in 2006 and in the Canadian market in 2009.
4 Alternative Therapies That Help With Your Energy Levels
If you feel as if your energy levels are just not as high as you would like, you may think the only way to see improvements is to visit a doctor and be prescribed medication. However, there are actually many other types of alternative therapies that can boost your energy levels and make you feel years younger. If you're tired of being tired all the time and want to be filled with plenty of energy day in and day out, try the following alternative therapies.
Tai Chi
An ancient Chinese form of exercise, tai chi is often credited with helping people relieve stress, become pain-free, and have increased energy levels. A low-impact exercise consisting of slow, controlled movements of your body, you can do tai chi on your own or join a local class. Easy to do and learn, it's a great alternative to other forms of exercise.
Light Therapy
If you suffer low energy levels during the winter months, it could be related to seasonal affective disorder, also known as SAD. Should this be the case, light therapy using things like the Visum Light can often be very helpful in getting your energy levels recharged. Since light therapy only takes a few minutes each day, it is an easy and convenient way to start feeling better.
Meditation
While you may think simply sitting still for a few minutes in your favorite chair will accomplish the same thing as meditation, you are wrong. Once you embrace meditation, you will start to reap immediate benefits regarding increased energy levels and focus. Whether you choose to meditate first thing each morning or at the end of your day, a few minutes of deep thought alone will be very beneficial.
Exercise
When you first think about exercising to increase your energy levels, you probably think this will only make you more tired than you already are each day. However, even moderate exercise, such as walking, can help to release endorphins that reduce fatigue and low energy. Best of all, experts agree that you only need about two or three hours of moderate activity each week to see great results. Thus, whether you start walking or decide to work in your yard, exercise is a great therapy to solve your low energy problems.
Once you decide to be proactive about increasing your energy levels, trying any of these alternative therapies should help start to notice improvements in your physical as well as mental energy.
Cutting Edge Foot and Ankle Clinic Treats All Problems of the Foot & Ankle
Cutting Edge Foot and Ankle Clinic in Nashville treats all problems of the foot and ankle and accepts same-day appointments.
Cutting Edge Foot and Ankle Clinic, located at 343 Dickerson Pike, Ste 740, Nashville, TN, uses the latest surgical and non-surgical techniques and procedures to improve their patients’ quality of life and make their feet happy and keep you moving.
Cutting Edge Foot and Ankle treats all conditions of the foot and ankle which include: dermatological skin diseases, such as plantar warts, ingrown toenails, and nail fungus. To deformities such as bunions, hammertoes and flatfeet. They are patient-oriented and pride themselves on same-day appointments, no matter the reason.
Dr. David Farnen, DPM is originally from Southern California but has been a Nashville native for several years. Dr. Farnen completed his B.S. in Biological Sciences from the University of California, Irvine, and obtained his doctorate from Rosalind Franklin University of Medicine and Science / Chicago Medical School in Chicago, Illinois. He then completed his surgical residency training at Eastern Virginia Medical School and the Sentara Hospital healthcare system. Dr. Farnen has a strong enthusiasm and commitment to research. During his medical training, he was awarded an NIH grant to research diabetes and peripheral neuropathy effects on the foot and ankle.
Dr. Farnen is a board-qualified foot-and-ankle surgeon by the American Board of Foot and Ankle Surgery, board-certified by the American Board of Podiatric Medicine with a subspecialty in limb salvage, wound care, and hyperbaric oxygen therapies. He specializes in all aspects, both surgical and non-surgical foot and ankle care. He has a passion for dermatological pathologies, diabetic foot care, wound care, and cutting-edge technologies (no pun intended) in foot and ankle care. Dr. Farnen is a member of the American Podiatric Medical Association and the American College of Foot and Ankle Surgeons.
Dr. Farnen says, "We strive to provide the best care and educate our staff, colleagues, and patients to put their best 'feet forward'. We treat our patients and their family members like our family, because they are a part of our family."
Cutting Edge Foot and Ankle Clinic
Cutting Edge Foot and Ankle Clinic offers the highest quality podiatric care in a comfortable, convenient, and compassionate setting. Our team of licensed professionals specializes in addressing global podiatric concerns in infants, children, teens, and adults. We take pride in diagnosing and treating a variety of foot problems and educating our patients on preventative techniques.
4 Ways You Can Help Yourself Through a Repetitive Strain Injury
When you have suffered a repetitive strain injury involving your hands, wrists, shoulder, neck, or other parts of your body, you suddenly realize just how hard it can be to accomplish even the simplest of tasks without being in pain. However, the good news is that repetitive strain injuries do eventually go away, provided you know what to do regarding proper treatment. If you want to help yourself get through a repetitive strain injury, here are four things you can do to get your body healed up and back on track.
Acupuncture
When you are in pain from a repetitive strain injury, acupuncture has been shown to be a very effective treatment. An ancient Chinese medical technique that has existed for thousands of years, more and more people now use this to get surprisingly effective results. By working with a skilled acupuncturist who can place needles into various pressure points of your body, your injury may heal much faster than you expected.
Physiotherapy
With its goal of restoring normal movement to injured body tissue, physiotherapy can be customized for your particular needs. Combining elements of electrotherapy, joint mobilization, and ergonomics, a physiotherapist from River Oaks Wellness and similar centers can work with you to develop a program emphasizing injury-specific exercises, ergonomics, and more to decrease the chances of the injury reoccurring later on.
Stretching Exercises
If you tend to lead a sedentary lifestyle and perhaps have a job where you sit at a desk working at a computer for hours at a time, the result can be muscles, tendons, and ligaments that over time become shortened and far less flexible, making it easier to sustain a repetitive strain injury. To help with this, stretching exercises are often used on patients with these injuries. Simple and easy to do, they may include stretching your fingers on both hands for 15-20 seconds for up to three times per day.
Massage
If you have an injury to your neck or shoulders, having regular massage therapy can be of tremendous benefit in your effort to heal. From deep-tissue massages to milder forms of massage therapy, visiting a certified massage therapist once a week or more if needed can help your muscles heal and relieve stress.
While it can be frustrating waiting for a repetitive strain injury to heal, using some of these treatment methods can help speed up the healing process. From acupuncture to physiotherapy and more, sticking to a treatment program will soon have you feeling as good as new.
4 Natural Ways to Ease Muscle Soreness After a Workout
After a great work out you may find yourself rewarded with sore muscles. Keep in mind that your muscles are just protein fibers that sustain intended damage during training. The goal should be to bring down the inflammation this process has caused. Instead of letting the cramps and soreness delay, next workout try a few natural remedies to keep your muscles strong and healthy.
Magnesium Supplements
Magnesium should be the go-to post-workout solution. When the body doesn’t have enough magnesium, the calcium then builds up causing cramps and spasms. Magnesium can be taken as a supplement or eat magnesium-rich foods post-workout like almonds, spinach, and cocoa. Epsom salt is a great place to start the healing journey, a warm bath with a cup of Epsom salt will help the muscles gather the magnesium out of the salty water. Be sure to check with your doctor if you take prescription medications before supplementing with magnesium.
Apple Cider Vinegar Drinks
Apple cider vinegar is both anti-inflammatory and alkalizing. Just what sore muscles need something to help reduce the inflammation. A teaspoon is all that is needed to start the muscle recovery process, it can be added to a cup of water if needed. It is also effective if applied topically.
CBD Cream
Sometimes muscle recovery needs a helping hand. A great solution is a 2000mg CBD joint pain cream. All you have to do is massage the affected area with the CBD cream and in about ten minutes the soreness will disappear. The skin absorbs the CBD, it is a powerful medicine (no prescription is needed). However, the CBD does not enter the bloodstream. It is more effective than the old sports menthols rubs that most folks are familiar with.
Turmeric Supplements
Internal support of reducing inflammation can be supplemented with turmeric. A 500mg capsule is all you need to help the body reduce inflammation after a workout. Turmeric is the ingredient in curry that gives it that yellow color and distinct flavor. It is not that exotic, turmeric capsules are readily available at drug stores and grocery stores. There are no side effects and it won’t put a taste in your mouth.
After a workout, there is no need to suffer from the pain and cramps of sore muscles. The four ingredients; magnesium, apple cider vinegar, CBD cream, and turmeric when used together treat muscles inside and outside. Natural remedies are safe to use. Together they provide a speedy recovery and no interruption in the workout schedule.
Roche Diabetes Care Canada collaborates with Ellerca Health to launch Accu-Chek® + 360Care™ for diabetes
Accu-Chek® + 360Care™ offers patients living with Type 1 and Type 2 diabetes innovative personalised solutions, empowering patients to actively monitor their glucose with real-time professional support, coaching using technology and human intervention
The Accu-Chek® Guide blood glucose meter along with "just in time" customized home testing strip delivery and Ellerca's 360Care™ app and health coaches help patients manage their health and worry less about their diabetes
Accu-Chek® + 360Care is an exclusive offer for Medavie Blue Cross plan members
LAVAL, QC, May 17, 2021 /CNW Telbec/ - Roche Diabetes Care Canada announces a collaboration with Ellerca Health, a Toronto-based company dedicated to improving patient care through innovation and technology. The partnership will include the launch of Accu-Chek® + 360Care™, combining Roche's Accu-Chek® Guide blood glucose meter, customized home delivery of testing strips and Ellerca's self-management digital program, 360Care™, which empowers patients to be in control of their own treatment schedule with access to a team of health coaches.
"At Roche Diabetes Care, we are dedicated to offering integrated, personalised diabetes management to Canadians living with diabetes," said Jade Dagher, Head of Sub-Region Canada, Australia and New-Zealand at Roche Diabetes Care. "This valuable partnership with Ellerca Health aims to further our mission to shape the future of diabetes management and help people living with diabetes take better control of diabetes and improve their disease outcome."
The Roche and Ellerca collaboration provides patients with a fully personalised and integrated solution that makes managing treatment easy and efficient. The offer consists of the Accu-Chek® Guide blood glucose meter, access to testing strips – which are sent directly to patients' homes and health coaching from a diabetes nurse educator, social worker, psychologist and/or nutritionist.
"We know that people living with diabetes and other chronic illnesses are looking for help and support throughout their health journey and we are proud to do our part to eliminate any added stress," said Daniel Yeboah, Founder + General Manager of Ellerca Health. "Through 360Care™, our virtual diabetes clinic and the help of partners like Roche we can help deliver life-changing solutions that empower patients to take back control of their daily lives."
Accu-Chek® + 360Care™ will be available to Medavie Blue Cross plan members as part of their Diabetes Care Program.
"This collaboration is a great example of companies coming together to create health solutions," said Marc Avaria, Vice President, Product and Disability Management at Medavie Blue Cross. "We are pleased to offer a robust Diabetes Care Program to plan members through our Managing Chronic Disease benefit. We will continue to focus on ways to enable better, more convenient access to education and care to help those with diabetes and other chronic conditions."
About Roche Diabetes Care Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines.
Being a global leader in integrated Personalised Diabetes Management (iPDM), Roche Diabetes Care collaborates with thought leaders around the globe, including people with diabetes, caregivers, healthcare providers and payers. Roche Diabetes Care aims to transform and advance care provision and foster sustainable care structures. Under the brands RocheDiabetes®, Accu-Chek® and mySugr®, comprising glucose monitoring, insulin delivery systems and digital solutions, Roche Diabetes Care unites with its partners to create patient-centred value. By building and collaborating in an open ecosystem, connecting devices and digital solutions as well as contextualising relevant data points, Roche Diabetes Care enables deeper insights and a better understanding of the disease, leading to personalised and effective therapy adjustments. For better outcomes and true relief.
Since 2017, mySugr®, one of the most popular diabetes management apps, is part of Roche Diabetes Care.
About Ellerca Health Based in Toronto, Canada, Ellerca Health, is a digital health organization that uses the integration of mobile technology, real human interaction, artificial intelligence, and proven behavioral science to revolutionize the personal experience and health outcomes of people living with chronic disease. Ellerca Health's approach delivers continuous fully integrated virtual care and support, raising the bar in the digital therapeutics market.
Shifting the healthcare paradigm to engage and empower consumers, Ellerca Health is transforming chronic disease management, patient outcomes, and healthcare costs with its 360Care™ platform.
Driving 360Care™ is the core philosophy that people with chronic health needs, when provided with true care and companionship, quickly make the incremental behavioral changes needed to stop the progression of their conditions.
About Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide. In 2019, Roche invested CHF 11.7 billion in R+D and posted sales of CHF 61.5 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.
Madison Systems Inc. - Stanmac Broadband Inc. Press Release
TORONTO, May 17, 2021 /CNW/ - Madison Systems Inc. (MADI-OTC NASDAQ) and Stanmac Broadband Inc. (SBI) update our future role in the delivery of our proprietary and patented broadband technology (6 to 8 years ahead of the industry) in partnership with an associate company, Infinity Internet Solutions. The number of subscribers on the East Prairie project has been increasing steadily, lives have changed completely, they are ecstatic and the ISED (Innovation, Science and Economic Development) of Canada is approving additional licenses to further expand our reach to communities, currently lacking access to high-speed broadband. Madison Systems Inc./Stanmac Broadband Inc new patented product development.
During the Covid-19 pandemic, we have seen an unparalleled reliance on high-speed internet. Students (for schooling), people (working from home), every business has had to adapt and join the online marketplace, it's the way of the future growth of businesses. Unfortunately, millions of people in Canada and the USA do not have access to this basic essential service. In 2017, Canadian census reported that 37 percent of rural households and 24 percent of Indigenous households in Canada lacked high-speed broadband access. In the USA, approximately 30 million Americans lack high-speed broadband. Demand is extraordinary and through strategic partnerships, numerous spectrum licenses and unparalleled patented technology, Madi/SBI is positioned to supply affordable, reliable broadband and bridge the digital divide.
Our patented Connect Gen systems deliver broadband through the UHF spectrum providing internet, TV, telephone, and security without interruption or interference. Each Connect Gen system provides high-speed broadband with speeds of 100 to 200Mbps and supplies subscribers in a radius up to 60km from our tower without line-of-sight. Connect Gen systems are engineered, tested and field proven utilizing DOCSIS 3 and Channel Bonding to provide unrivaled capabilities, reaching rural/remote communities (of 20,000 plus homes & businesses).
Madi/SBI has an aggressive expansion plan for Canada/USA for 2021 and 2022. Our goal is to install up to 20 systems by the end of the year in rural and remote communities in need; including Indigenous communities, small towns and remote summer and winter homes. Rapid growth and implementation of our Connect Gen systems is our goal, and with licenses allowing us to utilize existing tower infrastructure, we are positioned to achieve these goals.
The Ontario and Federal Governments has recently released their 2021 budget which included up to $6 billion in rural internet infrastructure funding. Madi/SBI and Infinity Internet Solutions plan on expanding through it's ability to supply high speed broadband service across northern Canada allowing remote Canadians to access reliable internet. While the big telecom companies continue to under-serve rural and remote areas across Canada and Northern US states, Madi/SBI utilizing the new patented high-speed broadband technology are dedicated to connecting these communities with affordable and dependable broadband, encouraging cultural sustainability and essential community growth.
Future growth into the US market will be pursued as part of Madi/SBI mandate. With nearly 30 million Americans without access and a $100 billion pledge by the US Government to expand access to all Americans over the next 8 years, the opportunity for expansion is endless, and Madi/SBI will pursue all opportunities.
Don McNally President/CEO,
Please catch up with us and read our first two press releases; Oct 2nd, 2018 and Apr 13th, 2021
This press release may include forward-looking information within the meaning of OTC Markets Pink Guidelines, concerning the business and trading in the common stock of Madison Systems Inc. (MADI-OTC NASDAQ) such information is based on assumptions made by the company's management. Although the company believes these assumptions are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove correct. These forward-looking statements are made as of the date of the press release and the company disclaims any obligation to update publicly any forward-looking information, other than required by applicable securities law.
The OTC Markets has not reviewed, approved, or disapproved the content of this press release.
SOURCE Madison Systems Inc.
Skylight Health Obtains Conditional Approval to List on NASDAQ Under the Symbol “SLHG”
TORONTO, May 13, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced that the Company has received conditional approval from The Nasdaq Stock Market LLC ( “Nasdaq”) to list its issued and outstanding common shares on Nasdaq. Final approval of the listing is subject to the Company fulfilling any remaining conditions as required by Nasdaq. The Company expects to satisfy all of the requirements and will issue a statement once a trading date has been confirmed by Nasdaq. The Company’s common stock will continue to trade in Canada on the TSX Venture Exchange under its current symbol SHG; and until the NASDAQ listing, in the U.S. on the OTCQX under its current symbol, SHGFF.
“The anticipated listing of our stock on the Nasdaq represents a significant milestone in our growth as a publicly-traded company,” said Prad Sekar, CEO and Co-Founder of Skylight Health. “We believe this anticipated listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in obtaining conditional approval for Skylight Health to list on Nasdaq, an important step that will help facilitate our mission to provide primary services to Americans across the country.”
The Company also announces a change in auditor from Grant Thornton LLP (“Former Auditor”) to PricewaterhouseCoopers LLP (“Successor Auditor”) effective May 4, 2021. In accordance with NI 51-102, the notice of change of auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been reviewed by the board of directors of the Company and filed on SEDAR.
About Skylight Health Group
Skylight Health Group (TSXV:SHG; OTCQX:SHGFF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state health network that comprises of physical multi-disciplinary medical clinics providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company owns and operates a proprietary electronic health record system that supports the delivery of care to patients via telemedicine and other remote monitoring system integrations.
The Company primarily operates a traditional insurable fee-for-service model contracting with Medicare, Medicaid and other Commercial Payors. The Company also offers a disruptive subscription-based telemedicine service for the un/under-insured population who have limited access to urgent care due to cost.
Currency Usage, Cautionary and Forward-Looking Statements
All currency contained in this Press Release represent Canadian Dollars unless otherwise stated.
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Skylight Health's filings with Canadian and United States securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the Company’s anticipated uplist to NASDAQ.
Although Skylight Health has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: the ability of Skylight Health to execute on its business strategy, continued revenue growth in accordance with management’s expectations, operating expenses continuing in accordance with management expectations, dependence on obtaining regulatory approvals; Skylight Health being able to find, complete and effectively integrate target acquisitions; change in laws relating to health care regulation; reliance on management; requirements for additional financing; competition; hindering market growth or other factors that may not currently be known by the Company.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Skylight Health disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Skylight Health does not assume any liability for disclosure relating to any other company mentioned herein.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
OBI's Data Releases Promise to Accelerate Discovery in Brain Health
Clinical data from over 5500 participants are ready to be mined by researchers for insights into brain health and disease
TORONTO, May 13, 2021 /CNW/ - The Ontario Brain Institute (OBI) announced the release of its first clinical data sets to promote open science and accelerate research in brain health through Brain-CODE, OBI's neuroinformatics platform. OBI's approach to data sharing offers the research community an opportunity to take advantage of clean, curated data to better understand brain disorders and identify new treatment options that would otherwise take years of work and resources.
Gathering large, well-curated datasets is a highly specialized, resource intensive process, but it has a big pay-off. By providing these assets to the international research community OBI aims to let researchers get right to the work. Using these data, researchers can delve into some of the most pressing questions and challenges that will ultimately improve quality of life for people living with brain disorders.
Designated a Privacy by Design ambassador by the Information and Privacy Commissioner of Ontario, Brain-CODE's safe and secure platform will make it easier for researchers, clinicians, and industry partners to collaborate with national and international research community in speeding up discovery.
"Data sharing fosters scientific discoveries by enabling the aggregation of multiple, disparate datasets as well as opening the process of gaining insights from the data to scientists not involved in the initial data gathering. Such democratization of data and science will lead to more robust and trustworthy results and conclusions", says Dr. Jason Lerch, Director, Preclinical Imaging, Wellcome Centre for Integrative Neuroimaging, University of Oxford and POND Investigator.
The first sets of clinical data were collected for research studies led by OBI's neurodevelopmental disorders (like autism) program (POND) and the Post-Concussive Problems In Pediatrics (5P) study that involved researchers from OBI's concussion research program (CONNECT). This set includes clinical data from over 5500 participants and later this year four more datasets including depression and neurodegenerative diseases (like Alzheimer's) will follow.
Currently, Brain-CODE has data from more than 20,000 participants across its six research programs: epilepsy, cerebral palsy, neurodegenerative diseases, neurodevelopmental disorders, depression and concussion. Brain-CODE's existing open data sets have been downloaded over 100 times during this past year alone with requests received from several countries including China, USA, Germany, Mexico and Australia.
"Science today is increasingly interdisciplinary, and researchers benefit enormously from having access to data and reliable information from various scientific fields," said Dr. Mona Nemer, Canada's Chief Science Advisor. "I am pleased to see that OBI has taken the lead on enabling open and safe sharing of research using an approach that reflects the values of transparency, inclusiveness and collaboration."
"The Ontario government is committed to supporting and recognizing scientific advances and innovations in the healthcare sector by Ontario's businesses and organizations to better the treatment and care of Ontarians," said Ross Romano, Minister of Colleges and Universities. "By sharing their first clinical data sets with the research community to better understand brain disorders and find new treatment options for those living with brain disorders, OBI continues to put Ontario on the map for its research and innovation in the brain health and healthcare sectors. OBI continues to develop ground-breaking research and 'Ontario Made' innovations and technologies that advance new discoveries and innovations that better the health and wellbeing of those living with brain disorders in our province."
"Improving brain health is a lofty goal, but by bringing the entire community together, OBI aims to unite us all under one banner to serve those in need," says Dr. Mikkelsen, President & Scientific Director, OBI. "Through the collaborative efforts of Ontario's community, we are breaking down barriers, encouraging a 'Team Science' approach to health research and most importantly honouring the time invested by our participants by reusing and recycling their data to help the generations to come."
If you wish to learn more about Brain-CODE or access the data releases, click here.
About Ontario Brain Institute:
The Ontario Brain Institute is a not-for-profit organization that accelerates discovery and innovation, benefiting both patients and the economy. Our collaborative 'team science' approach promotes brain research, commercialization and care by connecting researchers, clinicians, industry, patients, and their advocates to improve the lives of those living with brain disorders. Welcome to Brain Central. Visit www.braininstitute.ca for more information. Follow us on Twitter (@OntarioBrain). Funding provided, in part by, the Government of Ontario.
About Brain-CODE:
Brain-CODE is OBI's state-of-the-art neuroinformatics platform where data streams from OBI's six research programs and from institutions across Canada. Brain-CODE which is designed to store, manage and facilitate the analysis of data. OBI's Brain-CODE is a "shared brain" for researchers in Ontario and beyond. Please visit www.braincode.ca
SOURCE Ontario Brain Institute
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
